 |
Interferon beta-1a (recombinant) |
|---|---|
| Trade Name | Rebif |
| Orphan Indication | Symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3 |
| USA Market Approval | USA |
| USA Designation Date | 1992-12-02 00:00:00 |
| Sponsor | EMD Serono, Inc.;One Technology Place;Roackland, Massachusetts, 02370 |
